Skip to content
DAT Supply Log in
Other · Gummies

Astaxanthin

Astaxanthin is a naturally occurring carotenoid pigment sourced from the microalgae Haematococcus pluvialis. It is used in food supplements for its antioxidant properties. Under EU Regulation 432/2012, astaxanthin has no authorised health claims; any claim coverage on pack must come from co-formulated nutrients.

  • antioxidant support
  • skin health
  • eye health
Build a formula with this ingredient
Astaxanthin

At a glance

Definition
Astaxanthin is a naturally occurring carotenoid pigment sourced from the microalgae Haematococcus pluvialis. It is used in food supplements for its antioxidant properties. Under EU Regulation 432/2012, astaxanthin has no authorised health claims; any claim coverage on pack must come from co-formulated nutrients.
Common positionings
  • antioxidant protection
  • skin resilience
  • eye comfort
  • healthy ageing
  • sports recovery
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Astaxanthin is a keto-carotenoid pigment produced by the microalgae Haematococcus pluvialis. It is responsible for the pink-red colouration in salmon, shrimp, and flamingos. In food supplements, astaxanthin is positioned as a premium antioxidant ingredient, often used in formulations targeting skin health, eye comfort, and healthy ageing.

Brands choose astaxanthin for its distinctive red colour and its reputation as one of the most potent natural antioxidants. It is one of the most familiar and commercially understood gummy actives across EU and US markets. However, because astaxanthin has no authorised health claims under EU Regulation 432/2012, brands must rely on co-formulated nutrients such as Vitamin C or Vitamin E to carry claim coverage on pack.

Origin and history

Astaxanthin occurs naturally in marine environments, where microalgae produce it as a protective mechanism against oxidative stress. The primary commercial source is Haematococcus pluvialis, a freshwater microalga cultivated in controlled photobioreactor systems. Industrial production involves growing the algae under optimal light and nutrient conditions, then inducing stress to trigger astaxanthin accumulation.

The ingredient was authorised as a novel food in the EU in 2014 under Commission Implementing Decision 2014/155/EU. Since then, it has become a well-established ingredient in the premium supplement market, particularly in gummy formats where its natural red colour can be leveraged as a visual differentiator.

Scientific overview

Astaxanthin is a lipid-soluble carotenoid with a unique molecular structure that allows it to span cell membranes. It is known for its ability to neutralise singlet oxygen and scavenge free radicals. Unlike some other antioxidants, astaxanthin does not become pro-oxidative under normal physiological conditions. Its bioavailability is enhanced when consumed with dietary fats, which is relevant for gummy formulations that may include lipid-based carriers.

The primary commercial form is natural astaxanthin from Haematococcus pluvialis, typically supplied as an oleoresin or beadlet. Synthetic astaxanthin is also available but is less commonly used in the supplement market due to consumer preference for natural sources. The ingredient is heat-sensitive, which requires careful processing during gummy manufacturing to preserve stability.

Manufacturing watchpoints include maintaining low processing temperatures, protecting the ingredient from light and oxygen, and ensuring adequate dispersion in the gummy matrix. The cost-per-mg is higher than many other carotenoids, which positions astaxanthin as a premium ingredient suitable for higher-margin product lines.

Why brands use Astaxanthin

Astaxanthin is positioned as a premium antioxidant ingredient, often targeting consumers interested in skin health, eye comfort, and healthy ageing. It is one of the most familiar and commercially understood gummy actives across EU and US markets. The natural red colour of astaxanthin can be used as a visual cue on pack and in the gummy itself, differentiating the product from standard gummy supplements.

From a formulation perspective, astaxanthin is soluble in the gummy matrix and has good applicability for gummy manufacturing. However, its heat sensitivity requires careful temperature control during processing. The premium cost of astaxanthin means it is typically used at lower dosages (2–12 mg per serving) and often co-formulated with other nutrients to provide a broader benefit profile.

For pack copy, brands must remember that astaxanthin has no authorised health claims under EU Regulation 432/2012. Any claim coverage must come from co-formulated nutrients such as Vitamin C (for collagen formation) or Vitamin E (for cell protection). DAT reviews all claim wording per project to ensure compliance with EU Reg. 1924/2006. Certification status (vegan, kosher, halal) and shelf-life claims are confirmed per project and batch documentation.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Limited — use coated forms
Soluble in matrix
Yes
Cost tier
Premium

Forms available

  • Natural astaxanthin from Haematococcus pluvialis (oleoresin, beadlet, powder)

Dosage reference

No EU NRV established. Typical brand positioning ranges from 2–12 mg per daily serving. DAT confirms final dosage per project brief and target market.

Taste & sensory

Not characterized. DAT reviews taste-masking requirements per project.

Manufacturing notes

No specific formulation notes. Standard processing applies.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

EU-authorised health claims

EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.

Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.

Astaxanthin is a permitted novel food ingredient (Commission Implementing Decision 2014/155/EU) and food supplement ingredient. No authorised health claims under Reg. 432/2012. All pack copy must be reviewed for compliance with EU Reg. 1924/2006. DAT reviews per project.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. EFSA Panel on Dietetic Products, Nutrition and Allergies·EFSA Journal·2014

  2. Ambati RR, Phang SM, Ravi S, Aswathanarayana RG·Marine Drugs·2014

  3. Davinelli S, Nielsen ME, Scapagnini G·Nutrients·2018

  4. Giannaccare G, Pellegrini M, Senni C, Bernabei F, Scorcia V, Cicero AFG·Nutrients·2020

  5. Higuera-Ciapara I, Félix-Valenzuela L, Goycoolea FM·Critical Reviews in Food Science and Nutrition·2006

  6. European Commission·Official Journal of the European Union·2014

Catalogue match

Product concepts featuring Astaxanthin

Private-label product concepts where Astaxanthin appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Synergy data needs review. DAT reviews per project.

Care when combining with

Conflict data needs review. DAT reviews per project.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Astaxanthin on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Astaxanthin.

Project handoff

Develop a formula featuring Astaxanthin

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.